Electromed, Inc. financial data

Symbol
ELMD on NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
Location
500 Sixth Avenue Nw, New Prague, MN
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 592 % +8.49%
Quick Ratio 57.5 % -3.45%
Debt-to-equity 16.6 % -7.25%
Return On Equity 15.3 % +74.5%
Return On Assets 13.1 % +76.4%
Operating Margin 14.7 % +77.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.46M shares -1.44%
Common Stock, Shares, Outstanding 8.46M shares -1.42%
Entity Public Float 83.9M USD +4.04%
Common Stock, Value, Issued 85K USD -1.16%
Weighted Average Number of Shares Outstanding, Basic 8.56M shares +0.32%
Weighted Average Number of Shares Outstanding, Diluted 8.98M shares +2.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 57.1M USD +14.7%
Revenue from Contract with Customer, Excluding Assessed Tax 57.1M USD +14.7%
Cost of Revenue 13.3M USD +10.7%
Research and Development Expense 616K USD -25.2%
Operating Income (Loss) 8.38M USD +104%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.95M USD +110%
Income Tax Expense (Benefit) 2.48M USD +144%
Net Income (Loss) Attributable to Parent 6.47M USD +99.7%
Earnings Per Share, Basic 0.75 USD/shares +97.4%
Earnings Per Share, Diluted 0.72 USD/shares +94.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.9M USD +97.4%
Accounts Receivable, after Allowance for Credit Loss, Current 22.4M USD -4.64%
Inventory, Net 3.43M USD -23.3%
Assets, Current 41M USD +13.3%
Deferred Income Tax Assets, Net 2.15M USD +36.1%
Property, Plant and Equipment, Net 5M USD -9.6%
Operating Lease, Right-of-Use Asset 120K USD +36.4%
Other Assets, Noncurrent 90K USD -37.1%
Assets 48.9M USD +11%
Accounts Payable, Current 1.78M USD +68.8%
Employee-related Liabilities, Current 2.15M USD +16.6%
Liabilities, Current 7.42M USD +28.4%
Liabilities 7.43M USD +27.1%
Retained Earnings (Accumulated Deficit) 20.6M USD +8.65%
Stockholders' Equity Attributable to Parent 41.5M USD +8.55%
Liabilities and Equity 48.9M USD +11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.31M USD
Net Cash Provided by (Used in) Financing Activities -4.47M USD -15503%
Net Cash Provided by (Used in) Investing Activities -58K USD +56.4%
Common Stock, Shares Authorized 13M shares 0%
Common Stock, Shares, Issued 8.46M shares -1.42%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.22M USD -537%
Deferred Tax Assets, Valuation Allowance 258K USD +16.7%
Deferred Tax Assets, Gross 3.06M USD +25.3%
Operating Lease, Liability 87K USD -46%
Depreciation 202K USD 0%
Payments to Acquire Property, Plant, and Equipment 37K USD -66.1%
Lessee, Operating Lease, Liability, to be Paid 89K USD -47%
Property, Plant and Equipment, Gross 10.3M USD +2.45%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9K USD -88.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 80K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 6K USD -81.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -71.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8K USD -52.9%
Current Income Tax Expense (Benefit) 4K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 9K USD -47.1%
Additional Paid in Capital 20.8M USD +8.48%
Amortization of Intangible Assets 18K USD +50%
Deferred Tax Assets, Net of Valuation Allowance 2.15M USD +36.1%